Moderna
MRNA
#797
Rank
C$34.25 B
Marketcap
$89.10
Share price
-3.43%
Change (1 day)
-36.11%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: C$34.25 Billion

As of September 2024 Moderna has a market cap of C$34.25 Billion. This makes Moderna the world's 797th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024C$34.25 B-31.9%
2023C$50.29 B-46.29%
2022C$93.63 B-28.15%
2021C$130.32 B147.21%
2020C$52.71 B517.77%
2019C$8.53 B24.59%
2018C$6.84 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Moderna was reported to be:

C$34.25 Billion
by Yahoo Finance info icon info icon
C$34.25 Billion
by CompaniesMarketCap info icon info icon
C$34.25 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
C$0.16 B-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
C$402.85 B 1,076.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.13 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$47.69 B 39.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$318.86 B 830.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$3.50 B-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
C$536.00 B 1,464.98%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.03 B-88.21%๐Ÿ‡บ๐Ÿ‡ธ USA